Annual report pursuant to Section 13 and 15(d)

SEGMENTS

v3.22.2
SEGMENTS
12 Months Ended
Mar. 31, 2022
Segment Reporting [Abstract]  
SEGMENTS

8. SEGMENTS

 

We operate our businesses principally through two reportable segments: Aethlon, which represents our therapeutic business activities, and ESI, which represents our diagnostic business. Our reportable segments have been determined based on the nature of the potential products being developed. We record discrete financial information for ESI, consisting of patent maintenance costs.

 

Aethlon’s revenue is generated primarily from government contracts to date and ESI does not have any revenues or activities other than patent maintenance. We have not included any allocation of corporate overhead to the ESI segment.

 

The following tables set forth certain information regarding our segments:

               
    Fiscal Years Ended March 31,  
    2022     2021  
Revenues:            
Aethlon   $ 294,165     $ 659,104  
ESI            
Total Revenues   $ 294,165     $ 659,104  
                 
Operating Losses:                
Aethlon   $ (10,396,914 )   $ (7,867,547 )
ESI     (23,971 )     (23,952 )
Total Operating Loss   $ (10,420,885 )   $ (7,891,499 )
                 
Net Losses:                
Aethlon   $ (10,396,914 )   $ (7,867,547 )
ESI     (23,971 )     (23,952 )
Net Loss Before Non-Controlling Interests   $ (10,420,885 )   $ (7,891,499 )
                 
Cash:                
Aethlon   $ 17,072,222     $ 9,861,378  
ESI     197       197  
Total Cash   $ 17,072,419     $ 9,861,575  
                 
Total Assets:                
Aethlon   $ 19,417,757     $ 10,668,719  
ESI     197       197  
Total Assets   $ 19,417,954     $ 10,668,916  
                 
Depreciation and Amortization:                
Aethlon   $ 123,685     $ 39,939  
ESI            
Total Depreciation and Amortization   $ 123,685     $ 39,939  
                 
Capital Expenditures:                
Aethlon   $ 349,193     $ 59,881  
ESI            
Capital Expenditures   $ 349,193     $ 59,881